Damora Therapeutics
DMRA
#5408
Rank
HK$11.26 B
Marketcap
HK$182.01
Share price
-4.44%
Change (1 day)
39.47%
Change (1 year)

EPS for Damora Therapeutics (DMRA)

EPS in 2026 (TTM): -HK$29.42

According to Damora Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$29.55. In 2025 the company made an earnings per share (EPS) of -HK$31.20 an increase over its 2024 EPS that were of -HK$145.25.

EPS history for Damora Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$29.42-5.69%
2025-HK$31.20-78.52%
2024-HK$145.25-48.64%
2023-HK$282.82-40.61%
2022-HK$476.1918.54%
2021-HK$401.73-73.1%
2020-HK$1,493131.17%
2019-HK$645.9424.59%
2018-HK$518.46